1. Home
  2. MTEX vs LSTA Comparison

MTEX vs LSTA Comparison

Compare MTEX & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mannatech Incorporated

MTEX

Mannatech Incorporated

HOLD

Current Price

$6.70

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$4.19

Market Cap

16.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTEX
LSTA
Founded
1993
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0M
16.4M
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
MTEX
LSTA
Price
$6.70
$4.19
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
2.2K
58.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
210.00
6.98
EPS
N/A
N/A
Revenue
$117,866,000.00
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$6.59
$1.81
52 Week High
$12.45
$4.89

Technical Indicators

Market Signals
Indicator
MTEX
LSTA
Relative Strength Index (RSI) 32.70 50.65
Support Level N/A $4.03
Resistance Level $7.58 $4.79
Average True Range (ATR) 0.14 0.09
MACD -0.02 -0.10
Stochastic Oscillator 11.11 28.57

Price Performance

Historical Comparison
MTEX
LSTA

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: